NVO
Novo Nordisk·NYSE
--
--(--)
--
--(--)
2.72 / 10
Underperform
Technical analysis rates Novo Nordisk as Underperform (2.7/10). Bearish signals—MACD Death Cross, RSI overbought, and MACD Golden Cross—outweigh the lone bullish Long Lower Shadow, indicating weak momentum and heightened downside risk.
Analysis Checks(1/4)
Long Lower Shadow
Score7.89/10
Win Rate100.00%
Hist. Signals2
Avg Return1.65%
Score7.89/10
Win Rate100.00%
Hist. Signals2
Avg Return1.65%
MACD Death Cross
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-1.90%
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-1.90%
RSI Overbought
Score1/10
Win Rate33.33%
Hist. Signals12
Avg Return-0.74%
Score1/10
Win Rate33.33%
Hist. Signals12
Avg Return-0.74%
MACD Golden Cross
Score1/10
Win Rate28.57%
Hist. Signals7
Avg Return-5.01%
Score1/10
Win Rate28.57%
Hist. Signals7
Avg Return-5.01%
Long Lower Shadow
Score7.89/10
Win Rate100.00%
Hist. Signals2
Avg Return1.65%
Score7.89/10
Win Rate100.00%
Hist. Signals2
Avg Return1.65%
RSI Overbought
Score1/10
Win Rate33.33%
Hist. Signals12
Avg Return-0.74%
Score1/10
Win Rate33.33%
Hist. Signals12
Avg Return-0.74%
MACD Death Cross
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-1.90%
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-1.90%
MACD Golden Cross
Score1/10
Win Rate28.57%
Hist. Signals7
Avg Return-5.01%
Score1/10
Win Rate28.57%
Hist. Signals7
Avg Return-5.01%
Technical Analysis of NVO?
- NVO presents a Underperform setup with a Technical Score of 2.72/10. Key technical indicators highlight an RSI of 32.52 and a MACD of 0.76, with the trend anchored by the 50-Day SMA at 47.46. Traders should monitor key support at 36.46 and resistance at 37.19.
